Results 221 to 230 of about 51,125 (324)

Antimalarials in Lupus Nephritis: How Strong Is the Evidence? [PDF]

Kidney360
Caravaca-Fontán F, Yandian F, Zand L, Sethi S, Fervenza FC.   +4 more
europepmc   +1 more source

Plant‐Based Mycetoma Inhibitors Targeting the 50S Ribosomal Protein of Nocardia brasiliensis: In Silico Approach

ChemistrySelect, Volume 10, Issue 21, June 4, 2025.
In‐silico drug discovery pipeline for Mycetoma caused by Nocardia brasiliensis. A library of 1034 phytocompounds was screened to identify potent inhibitors, with Parviflorone F showing strong binding and stability against the 50S ribosomal unit. Molecular dynamics confirmed its inhibitory potential, offering a promising therapeutic candidate.
Sandra Jose, Manjunathan Jagadeesan, Meenambiga Setti Sudharsan, Pasiyappazham Ramasamy, Shyamala Gowri, Muthu Thiruvengadam, Sowmya Hari, Baskar Venkidasamy   +7 more
wiley   +1 more source

The Value and Dangers of Antimalarial Therapy in Arthritis with Special Relation to the Ophthalmic Complications

, 1964
G. D. Kersley
openalex   +1 more source

Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. [PDF]

, 1990
François Nosten, Juntra Karbwang, Nicholas J. White, Honeymoon, Kesara Na Bangchang, D Bunnag, T Harinasuta   +6 more
openalex   +1 more source

Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain. [PDF]

Pediatr Rheumatol Online J
Boteanu A, Bethencourt JJ, Calzada-Hernández J, Clemente D, Nieto-González JC, López C, Luque L, Calvo I.   +7 more
europepmc   +1 more source

Exploring Use of a Protein Cage System for Producing Bioactive Peptides in Escherichia coli

Microbial Biotechnology, Volume 18, Issue 6, June 2025.
Bioactive peptides can be difficult to manufacture biosynthetically. This study explored the use of bacteriophage P22 virus‐like particles to encapsulate recombinantly expressed bioactive peptides, enabling the production of therapeutically valuable linear and cyclic peptides in Escherichia coli.
Maxim D. Harding, Mark A. Jackson, Edward K. Gilding, Kuok Yap, David J. Craik, Frank Sainsbury, Nicole Lawrence   +6 more
wiley   +1 more source

Antimalarial Activities of Various 4-Quinolinemethanols with Special Attention to WR-142,490 (Mefloquine)

, 1978
L. H. Schmidt, Ruth Crosby, Jane F. Rasco, Dennis Vaughan   +3 more
openalex   +1 more source

Synthesis of some new quinoline derivatives - potential antimalarial drugs [PDF]

, 1990
R. Vlahov, St. Parushev, J. Vlahov, Peter Nickel, Günther Snatzke   +4 more
openalex   +1 more source

Real-world treatment patterns, healthcare resource utilisation and costs in patients with SLE in the USA. [PDF]

Lupus Sci Med
Masurkar PP, Reckleff J, Princic N, Limone B, Schwartz H, Karis E, Zollars E, Costenbader K.   +7 more
europepmc   +1 more source

Evaluating the impact of general practice pharmacist‐led person‐centred medicines reviews on medicines appropriateness and patient‐reported outcome measures

British Journal of Clinical Pharmacology, Volume 91, Issue 6, Page 1802-1820, June 2025.
Abstract Aim The aim of this study was to investigate the impact of pharmacist‐led person‐centred medicines reviews in general practices on medicines appropriateness, polypharmacy indicators (high‐risk prescribing markers), and patient‐reported outcome measures (PROMs).
Clare Kinahan, Ciara Kirke, Leon O'Hagan, Frank Moriarty, Kevin D. Murphy, Laura J. Sahm, Cian O'Mahony, Emma J. Coyle, Stephen Byrne, Kieran Dalton   +9 more
wiley   +1 more source